Source: Rare Disease and Orphan Drug Journal Abstract One of the main challenges in rare diseases is the unavailability of reliable estimates of prevalence and
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
JoTo PR Disruptors’ signs Jeeva Trials, a human-centric Software as a Service (SaaS) company that is working to revolutionize the clinical trials space at scale.
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
Source: Pharmaceutical Outsourcing The outbreak of the COVID-19 pandemic seriously disrupted new drug testing, treatments, and in-person healthcare services; access to clinical trial sites was
Evidence linking interventions with health outcomes is vital for healthcare decision-making. Making sound choices about healthcare requires the best possible and quality evidence from clinical
Even though the COVID-19 pandemic raised global awareness of clinical trials, most adults have never seen an advertisement recruiting volunteers to participate. In the U.S.,
Patient test groups for new drugs and treatments, notes Dr. Harsha Rajasimha of Jeeva Trials, tend to be non-diverse. However, recently developed digital health technologies
Feb 3, 2021 By Harsha Rajasimha, Ph.D. & Sharlene Brown, Ph.D. Patient groups can optimize patient registries, cross-sectional studies, and/or longitudinal natural history studies to
By Harsha Rajasimha, Ph.D. & Sharlene Brown, Ph.D. 12/03/2020 When clinical investigators and study coordinators start planning a new study design, speed and efficiency are
Jeeva Clinical Trials Inc.
